TECHIZER TECH SOLUTIONS PRIVATE LIMITED

Specialized Pharmaceutical Digital Marketing Company

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Today, about 36 million people across the globe r blind. Together on 8th October 2020, World Sight Day let’s use our vision for elimination of preventable blindness & vision loss. Also, get actively involved & interact with people who r blind or vision impaired in the community.

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Cardiovascular disease (CVD) is the number one cause of death on the planet. Together, on World Heart Day, let’s commit ourselves to start listening to our heart, start taking care of our heart and most importantly beat cardiovascular disease by staying aware.
#worldheartday

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Maharashtra releases advisory on judicious use of remdesivir https://t.co/PBE1eD0wQf via @ETHealthWorld

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

World Alzheimer’s Day

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Today, on World Alzheimer’s Day, let’s pledge to make everyone understand the implication and criticality of Alzheimer disease.
#alzheimers #dementia #alzheimersawareness #caregiver #dementiaawareness #seniorcare #alzheimersassociation #alzheimer #dementiacare #alzheimersdisease

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Roche drug that previously failed in Covid-19 pneumonia shows efficacy in Phase III study https://t.co/0xJfMnZCas

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK https://t.co/vKPIcuwQhn via @ETHealthWorld

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Johnson & Johnson Aiming to Enroll One-Third of Phase 3 Trial Patients From Latin America @themotleyfool #stocks $JNJ $MRNA https://t.co/2p3D0jru1z

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

In the footsteps of AstraZeneca, Novartis commits to carbon-neutral supply chain by 2030 - https://t.co/ODBzYMeg8K

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

90% of countries report disruptions to essential health services since COVID-19 pandemic: WHO global pulse survey

https://t.co/MzhM6zywol

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

India may get COVID-19 vaccine by early 2021, says Bernstein Research https://t.co/DKpjhg7YZM via @economictimes

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData @ExpPharma https://t.co/vNrK6AIghs

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Russia begins production of COVID-19 vaccine @ExpPharma https://t.co/O25drb7gMi

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

J&J - Bio E aims to manufacture 400mn doses of Covid vaccine in a year: Paul Stoffels https://t.co/Lr1E7zYZvt via @economictimes

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800 per 100 mg vial https://t.co/euFywjztha via @economictimes

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

AstraZeneca in first COVID-19 vaccine deal with Chinese company https://t.co/YsILhyNrUg

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Alkem launches favipiravir under brand name Alfluenza @ExpPharma https://t.co/o9Kwovt3Nt

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Sun Pharma latest to sell COVID-19 drug favipiravir in India, to cost Rs 35 per tablet https://t.co/VtLcVnjM27 via @economictimes

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate @ExpPharma https://t.co/fqZi5XPzO8

[TECHIZER TECH SOLUTIONS PRIVATE LIMITED @techizer_tech]

Hetero launches generic version of COVID-19 drug favipiravir in India

https://t.co/pBmvXIknna